Kenneth Emancipator

Title: Innovations of Kenneth Emancipator

Introduction

Kenneth Emancipator is a notable inventor based in Bernardsville, NJ (US). He has made significant contributions to the field of medical therapies, particularly in the area of anti-PD therapy. With a total of 4 patents to his name, his work has the potential to impact the treatment of malignancies.

Latest Patents

One of Kenneth's latest patents focuses on scoring methods for anti-PD therapy eligibility and compositions for performing the same. This patent provides methods for determining the eligibility of a subject with a malignancy for treatment with an anti-PD therapeutic agent based on a Combined Positive Score (CPS) for a tumor tissue sample. The patent also includes compositions and kits for performing the disclosed methods, showcasing his innovative approach to improving cancer treatment.

Career Highlights

Throughout his career, Kenneth has worked with prominent companies such as Merck Sharp & Dohme Corp. and Agilent Technologies, Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical technology.

Collaborations

Kenneth has collaborated with talented individuals in his field, including Greg Angelides and Karina Kulangara. These partnerships have likely enriched his work and fostered innovation in his projects.

Conclusion

Kenneth Emancipator's contributions to the field of anti-PD therapy demonstrate his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving treatment options for patients with malignancies.